R&D Tax Credit Advance for Healthcare
Healthcare innovation companies — medtech, biotech, pharmaceutical, digital health, and diagnostics — invest heavily in R&D with long development cycles before revenue materialises. An R&D advance brings forward the tax credit cash so you can fund clinical trials, regulatory submissions, prototyping, and product development without additional equity dilution.
Healthcare R&D claims tend to be large relative to company size because R&D spending is the primary activity. This makes R&D advances particularly valuable for the sector.
Key Benefits
- Fund clinical trials and regulatory submissions from R&D credits
- Large claims relative to company size — maximise the advance
- Non-dilutive funding for R&D-intensive healthcare companies
- Bridge the gap between R&D spending and commercial revenue
Frequently Asked Questions
What healthcare R&D qualifies?
Medical device development, pharmaceutical formulation, clinical trial design and execution, diagnostic test development, software for healthcare applications, and biological research all qualify where there is technical uncertainty and advancement.
Can clinical trial costs be included?
Costs directly related to the scientific/technical aspects of clinical trials (protocol development, data analysis, novel methodology) are likely qualifying. Patient recruitment and administrative costs generally are not.
What about MHRA regulatory costs?
Regulatory submissions involve significant technical work that may qualify. The technical documentation, testing, and validation work required for MHRA or FDA submissions often contains qualifying R&D expenditure.
How does the merged scheme affect healthcare claims?
Under the merged scheme (from April 2024), all companies claim at the same 20% rate (or 27% for loss-making R&D intensive companies). Healthcare companies with high R&D:revenue ratios often qualify for the enhanced rate.
Related Funding Options
R&D Tax Credit Advance for Tech Companies
Get early access to your R&D tax credit claim. Advance funding for UK SaaS and technology businesses claiming R&D relief.
Unsecured Business Loans for Healthcare
Funding for UK dental practices, clinics, pharmacies, and private healthcare businesses. Equipment, expansion, and working capital.
Revenue-Based Finance for Tech Companies
Non-dilutive growth capital for UK SaaS and tech businesses. Fund product development, hiring, and marketing without giving away equity.
Ready to Get Funded?
Submit your details and we'll match you with the right lenders from our panel. No obligation, no fees.
Learn About Our Broker NetworkCoreFi is a trading name of JG Core Ltd (Company #16218779, England & Wales). CoreFi acts as a commercial finance broker and does not provide regulated financial advice. All products described are unregulated business-to-business finance. Information on this page is for general guidance only and does not constitute a formal offer of finance. Terms, rates, and availability are subject to lender criteria and may change without notice.